Solara Active Pharma Sciences's total inventories for the quarter that ended in Mar. 2026 was ₹3,179 Mil. Solara Active Pharma Sciences's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ₹1,589 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Solara Active Pharma Sciences's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹-110.41.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Solara Active Pharma Sciences's Days Inventory for the
three
months ended in Mar. 2026 was 73.45.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Solara Active Pharma Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.24.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Solara Active Pharma Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.41.
Solara Active Pharma Sciences (NSE:SOLARAPP1) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Solara Active Pharma Sciences's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Solara Active Pharma Sciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Solara Active Pharma Sciences Total Inventories Related Terms
Solara Active Pharma Sciences Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solara Active Pharma Sciences Total Inventories Chart
Solara Active Pharma Sciences Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a Total Inventories of ₹3,179 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Solara Active Pharma Sciences and its competitors.
Is Solara Active Pharma Sciences' Total Inventories too high?
Solara Active Pharma Sciences' current Total Inventories is ₹3,179 Mil. Overall, Solara Active Pharma Sciences has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' Total Inventories compare to ZTS and UTHR?
Solara Active Pharma Sciences' Total Inventories of ₹3,179 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Solara Active Pharma Sciences and its competitors. Solara Active Pharma Sciences's current Total Inventories is ₹3,179 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current Total Inventories of ₹3,179 Mil. The stock's GF Value™ is ₹263.62, compared to a current price of ₹267.45 — trading 1.5% above its estimated fair value. The current Total Inventories is ₹3,179 Mil. Solara Active Pharma Sciences' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current Total Inventories is ₹3,179 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?
Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued.
The current stock price of ₹267.45 is trading 1.5% above its estimated GF Value™ of ₹263.62.
Key valuation signals for NSE:SOLARAPP1:
Total Inventories: ₹3,179 Mil
GF Value™: ₹263.62 vs. price of ₹267.45 (1.5% above fair value)
No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Solara Active Pharma Sciences Business Description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
67GF Score
Get the complete analysis for NSE:SOLARAPP1
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOLARAPP1 has been successfully added to your 
